5-1293991-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_198253.3(TERT):c.895G>A(p.Val299Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000953 in 1,574,112 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_198253.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TERT | NM_198253.3 | c.895G>A | p.Val299Met | missense_variant | 2/16 | ENST00000310581.10 | NP_937983.2 | |
TERT | NM_001193376.3 | c.895G>A | p.Val299Met | missense_variant | 2/15 | NP_001180305.1 | ||
TERT | NR_149162.3 | n.974G>A | non_coding_transcript_exon_variant | 2/13 | ||||
TERT | NR_149163.3 | n.974G>A | non_coding_transcript_exon_variant | 2/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TERT | ENST00000310581.10 | c.895G>A | p.Val299Met | missense_variant | 2/16 | 1 | NM_198253.3 | ENSP00000309572.5 | ||
TERT | ENST00000334602.10 | c.895G>A | p.Val299Met | missense_variant | 2/15 | 1 | ENSP00000334346.6 | |||
TERT | ENST00000460137.6 | n.895G>A | non_coding_transcript_exon_variant | 2/13 | 1 | ENSP00000425003.1 | ||||
TERT | ENST00000656021.1 | n.895G>A | non_coding_transcript_exon_variant | 2/17 | ENSP00000499759.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152192Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000377 AC: 7AN: 185886Hom.: 0 AF XY: 0.0000396 AC XY: 4AN XY: 100920
GnomAD4 exome AF: 0.00000985 AC: 14AN: 1421920Hom.: 0 Cov.: 35 AF XY: 0.00000993 AC XY: 7AN XY: 704628
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152192Hom.: 0 Cov.: 34 AF XY: 0.0000135 AC XY: 1AN XY: 74346
ClinVar
Submissions by phenotype
Aplastic anemia;C0023467:Acute myeloid leukemia;C3151443:Dyskeratosis congenita, autosomal dominant 2;C3553617:Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1;C3554574:Melanoma, cutaneous malignant, susceptibility to, 9;C4551974:Dyskeratosis congenita, autosomal dominant 1;C5561926:Interstitial lung disease 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 12, 2021 | - - |
Dyskeratosis congenita Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 30, 2024 | The p.V299M variant (also known as c.895G>A), located in coding exon 2 of the TERT gene, results from a G to A substitution at nucleotide position 895. The valine at codon 299 is replaced by methionine, an amino acid with highly similar properties. This variant was reported as heterozygous in multiple individuals with features consistent with TERT-related disorder (Calado RT et al. Proc Natl Acad Sci U S A, 2009 Jan;106:1187-92; Mirabello L et al. JAMA Oncol, 2020 May;6:724-734). Functional studies suggest that the variant has no major effect on telomerase activity; however, additional evidence is needed to confirm these findings (Calado RT et al. Proc Natl Acad Sci U S A, 2009 Jan;106:1187-92; Zaug AJ et al. Nucleic Acids Res, 2013 Oct;41:8969-78). This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. - |
Idiopathic Pulmonary Fibrosis;C3151443:Dyskeratosis congenita, autosomal dominant 2 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 09, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at